Cite
HARVARD Citation
Duchesne, G. et al. (n.d.). Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. Lancet oncology. 17 (6), pp. 727-737. [Online].